Panacea Life Sciences Holdings, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Panacea Life Sciences Holdings, Inc. (PLSH) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $548.62 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-05-06
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-03-31 was $548.62K, a 37.14% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-12-31 was $326.12K, a 9.33% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-09-30 was $625.93K.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-06-30 was $634.51K, a 41.26% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.99M, a 83.40% increase from fiscal 2022.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.08M, a 1.26% increase from fiscal 2021.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $1.07M, a 63.34% increase from fiscal 2020.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $654.89K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | $548.62K 10-Q · filed 2024-05-06 | $874.74K derived: sum of 2 quarters · filed 2024-05-06 | $1.50M derived: sum of 3 quarters · filed 2024-05-06 | $2.14M derived: sum of 4 quarters · filed 2024-05-06 | |||
| 2023-12-31 | $326.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $952.04K derived: sum of 2 quarters · filed 2024-04-01 | $1.59M derived: sum of 3 quarters · filed 2024-04-01 | $1.99M 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $625.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.26M derived: sum of 2 quarters · filed 2023-11-14 | $1.66M 10-Q · filed 2023-11-14 | $2.02M derived: sum of 4 quarters · filed 2024-05-06 | |||
| 2023-06-30 | $634.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $1.03M 10-Q · filed 2023-08-15 | $1.39M derived: sum of 3 quarters · filed 2024-05-06 | $1.14M derived: sum of 4 quarters · filed 2024-05-06 | |||
| 2023-03-31 | $400.06K 10-Q · filed 2024-05-06 | $759.73K derived: sum of 2 quarters · filed 2024-05-06 | $500.77K derived: sum of 3 quarters · filed 2024-05-06 | $949.94K derived: sum of 4 quarters · filed 2024-05-06 | |||
| 2022-12-31 | $359.67K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $100.71K derived: sum of 2 quarters · filed 2024-04-01 | $549.88K derived: sum of 3 quarters · filed 2024-04-01 | $1.08M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$258.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $190.21K derived: sum of 2 quarters · filed 2023-11-14 | $723.52K 10-Q · filed 2023-11-14 | $837.70K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $449.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $982.47K 10-Q · filed 2023-08-15 | $1.10M derived: sum of 3 quarters · filed 2023-08-15 | $1.39M derived: sum of 4 quarters · filed 2023-08-15 | |||
| 2022-03-31 | $533.31K 10-Q · filed 2023-05-12 | $533.31K 10-Q · filed 2022-05-13 | $647.49K derived: sum of 2 quarters · filed 2023-05-12 | $941.60K derived: sum of 3 quarters · filed 2023-05-12 | $1.17M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $114.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $408.29K derived: sum of 2 quarters · filed 2023-03-30 | $633.09K derived: sum of 3 quarters · filed 2023-03-30 | $1.07M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $294.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $518.91K derived: sum of 2 quarters · filed 2022-11-14 | $955.49K 10-Q · filed 2022-11-14 | -$976.07K 10-Q · filed 2021-11-22 | $384.24K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $224.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $661.38K 10-Q · filed 2022-08-15 | $1.39M 10-Q · filed 2021-08-23 | $90.12K derived: sum of 3 quarters · filed 2022-08-15 | -$475.28K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $436.58K 10-Q · filed 2022-05-13 | -$134.68K derived: sum of 2 quarters · filed 2022-05-13 | -$700.08K derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$571.26K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$1.14M derived: sum of 2 quarters · filed 2022-03-31 | $654.89K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$565.40K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2021-12-20 | $1.23M 10-Q/A · filed 2021-12-20 | |||||
| 2020-06-30 | $1.79M 10-Q/A · filed 2021-12-20 | $761.38K 10-Q · filed 2021-08-23 |